Big pharma want in on stem cells without question. BUT they are in competition with eachother.
AND they wanted cheap deals with MSB. Think logically. They aren't a charity.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-323
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
-0.010(1.06%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 95.0¢ | 92.5¢ | $632.3K | 679.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 10649 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 30545 | 11 |
View Market Depth
| Last trade - 10.52am 16/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |